Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control

NCT01626248 · clinicaltrials.gov ↗
COMPLETED
Status
164
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

John F. Foley, MD

Collaborators